Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Minerva Neurosciences (NERV) Equity Ratio (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Equity Ratio readings, the most recent being 0.1 for Q4 2021.

  • On a quarterly basis, Equity Ratio fell 88.68% to 0.1 in Q4 2021 year-over-year; TTM through Dec 2021 was 0.1, a 88.68% decrease, with the full-year FY2021 number at 0.1, down 88.68% from a year prior.
  • Equity Ratio hit 0.1 in Q4 2021 for Minerva Neurosciences, down from 0.29 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.91 in Q4 2020 to a low of 0.1 in Q4 2021.
  • Median Equity Ratio over the past 3 years was 0.36 (2019), compared with a mean of 0.49.
  • Biggest five-year swings in Equity Ratio: soared 154.95% in 2020 and later crashed 88.68% in 2021.
  • Minerva Neurosciences' Equity Ratio stood at 0.36 in 2019, then surged by 154.95% to 0.91 in 2020, then tumbled by 88.68% to 0.1 in 2021.
  • The last three reported values for Equity Ratio were 0.1 (Q4 2021), 0.29 (Q3 2021), and 0.34 (Q2 2021) per Business Quant data.